Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity (Tables)

v3.22.2.2
Shareholders' Equity (Tables)
9 Months Ended
Oct. 29, 2022
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of warrants outstanding

    

Warrants

    

Warrants

    

Exercise Price

    

Grant Date

Outstanding

Exercisable

(Per Share)

Expiration Date

May 2, 2019

 

349,998

 

349,998

$

15.00

 

May 2, 2024

April 17, 2020

367,197

367,197

$

2.66

April 14, 2025

May 22, 2020

122,398

122,398

$

2.66

April 14, 2025

June 8, 2020

122,399

122,399

$

2.66

April 14, 2025

June 12, 2020

122,398

122,398

$

2.66

April 14, 2025

July 11, 2020

244,798

244,798

$

2.66

April 14, 2025

May 16, 2022

5,537,459

5,537,459

$

2.94

May 14, 2028

July 22, 2022

97,720

97,720

$

2.94

July 20, 2028

July 22, 2022

1,628,665

1,628,665

$

2.94

July 20, 2028

September 7, 2022

568,182

$

0.88

September 7, 2027

Schedule of stock options valuation assumptions

    

Fiscal 2022

Expected volatility:

 

82-83%

Expected term (in years):

 

6 years

Risk-free interest rate:

 

2.4-2.7%

Schedule of stock option activity

A summary of the status of the Company’s stock options outstanding as of October 29, 2022 and changes during the nine months then ended is as follows:

2020 Plan

2011 Plan

2004 Plan

Option

Weighted Average

Option

Weighted Average

Option

Weighted Average

Shares

Exercise Price

Shares

Exercise Price

Shares

Exercise Price

Balance outstanding, January 29, 2022

147,500

$

7.33

 

25,700

$

10.04

 

3,000

$

53.49

Granted

51,000

$

3.44

 

$

 

$

Exercised

$

 

$

 

$

Forfeited or canceled

(31,000)

$

5.95

 

(10,000)

$

10.87

 

$

46.20

Balance outstanding, October 29, 2022

167,500

$

6.40

 

15,700

$

9.51

 

3,000

$

54.70

Options exercisable at October 29, 2022

36,000

$

7.45

 

15,700

$

9.51

 

3,000

$

54.70

Schedule of stock options outstanding, vested and expected to vest

The following table summarizes information regarding stock options outstanding as of October 29, 2022:

Options Outstanding

Options Vested or Expected to Vest

Weighted

Weighted

Weighted

Average 

Weighted

Average 

Average 

Remaining 

Aggregate

Average 

Remaining 

Aggregate

Number of

Exercise 

Contractual 

Intrinsic 

Number of

Exercise 

Contractual 

Intrinsic 

Option Type

Shares

Price

 

Life (Years)

Value

Shares

Price

 

Life (Years)

Value

2020 Plan

167,500

$

6.40

8.9

$

148,800

$

6.42

8.9

$

2011 Plan

 

15,700

$

9.51

 

5.3

$

 

15,700

$

9.51

 

5.3

$

2004 Plan

 

3,000

$

54.70

 

1.4

$

 

3,000

$

54.70

 

1.4

$

Schedule of restricted stock unit activity

A summary of the status of the Company’s non-vested restricted stock unit activity as of October 29, 2022 and changes during the nine-month period then ended is as follows:

Restricted Stock Units

Market-Based Units

Time-Based Units

    

Performance-Based Units

    

Total

    

    

Weighted

    

    

Weighted

    

Weighted

    

Weighted

Average

Average 

Average

Average 

Grant Date

Grant Date 

Grant Date

Grant Date 

Shares

    

Fair Value

    

Shares

Fair Value

    

Shares

    

Fair Value

    

Shares

Fair Value

Non-vested outstanding, January 29, 2022

 

57,800

$

3.47

 

1,031,300

$

7.46

 

222,900

$

4.13

1,312,000

$

6.72

Granted

 

$

 

985,600

$

3.71

 

36,400

$

1.69

1,022,000

$

3.64

Vested

 

$

 

(453,000)

$

6.67

 

$

(453,000)

$

6.67

Forfeited

 

$

 

(78,600)

$

5.02

 

$

(78,600)

$

5.02

Expired

(12,500)

$

5.07

 

$

 

$

(12,500)

$

5.07

Non-vested outstanding, October 29, 2022

 

45,300

$

3.02

 

1,485,300

$

5.34

 

259,300

$

3.79

1,789,900

$

5.06